Elevated asset valuations and historically compressed credit spreads, she said, are not just indications “that policy most likely isn’t very restrictive. They’re also indications that the fed funds rate needs to offset tailwinds from financial conditions,” Logan said
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,